US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist

12.260
+0.050+0.41%

Close Feb 14 16:00 ET

12.500
+0.240+1.96%

Post 20:01 ET

1.24BMarket Cap-12.64P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Day One Biopharmaceuticals Q4 2024 Estimates Date

Currency：USDFeb 25, 2025

	Estimate	YoY
Revenue	27.79M	--
EPS	-0.36	+43.37%

Analyst Rating

Strong Buy

Feb 10, 2025

Day One Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 33.150M	--
Feb 25, 2025	2024/Q4	-- / 27.790M	--
Oct 30, 2024	2024/Q3	93.761M / 28.451M	--
Jul 30, 2024	2024/Q2	8.192M / 912.220K	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 33.150M--

Feb 25, 20252024/Q4-- / 27.790M--

Oct 30, 20242024/Q393.761M / 28.451M--

Jul 30, 20242024/Q28.192M / 912.220K--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Day One Biopharmaceuticals Earnings Reports

Day One Biopharmaceuticals | 10-Q: Q3 2024 Earnings Report

Oct 30, 2024 16:07 ET

Day One Biopharmaceuticals | 8-K: Day One Reports Third Quarter 2024 Financial Results and Corporate Progress

Oct 30, 2024 16:03 ET

Day One Biopharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 2, 2024 16:13 ET

Day One Biopharmaceuticals | 8-K: Day One Reports Second Quarter 2024 Financial Results and Corporate Progress

Jul 30, 2024 07:40 ET